-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A DNAzyme (red) uses its binding arm to dock at a specific position on the RNA strand (yellow) and then cleave it at its core
DNAzymes (DNAzymes ) DNAzymes are a precise biological catalyst that can destroy unwanted RNA molecules
DNAzymes-a word composed of DNA and enzymes-are DNA sequences with catalytic activity
Its purpose is to target unwanted RNA molecules in viruses, cancers or damaged nerve cells, using DNAzymes to attack and destroy them
The benefits of this therapy are obvious: unwanted RNA can be precisely destroyed, while other useful RNA strands in the cell remain intact
Dr.
In their research, authors from HHU and a team from the Jülich Research Center (FZJ), the University of Bonn, and a Swiss company tried to understand how the system as a whole works dynamically, and what steps take place in the process of combining and disintegrating.
The researchers observed this process at atomic resolution and performed some real-time observations using a high-resolution nuclear magnetic resonance (NMR) spectrometer
The team of Professor Holger Gohlke, Chairman of HHU Pharmaceutical and Medicinal Chemistry and FZJ Institute of Biological and Earth Sciences conducted molecular dynamics simulations of DNAzyme/RNA complexes, adding: “In the sense of the best integrated modeling, we can propose atomic The level of reliable RNA cleavage mechanism, and provides information on the RNA base preference at the cleavage site
Jan Borggräfe, a PhD researcher in the Etzkorn working group and the lead author of the study, explained why DNAzymes do not work well in cells: "We have identified magnesium as a key cofactor, which plays a variety of important roles in this mechanism, but it The binding to DNAzyme is relatively poor, and it only binds briefly
The next step is to conduct structural studies on cell culture and organoids
Dr.
Professor Dieter Willbold, Director of the Harvard Institute of Physical Biology and FZJ Institute of Structural Biochemistry, added: "This research is yet another example of how fundamental research in structural biology can provide an important contribution to breakthrough biomedical progress
References: “Time-resolved structural analysis of an RNA-cleaving DNA catalyst” by Jan Borggräfe, Julian Victor, Hannah Rosenbach, Aldino Viegas, Christoph GW Gertzen, Christine Wuebben, Helena Kovacs, Mohanraj Gopalswamy, Detlev Riesner, Gerhard Steger, Olav Schiemann, Holger Gohlke, Ingrid Span and Manuel Etzkorn, 23 December 2021, Nature .